Alpha Teknova Inc (TKNO) - Total Assets
Based on the latest financial reports, Alpha Teknova Inc (TKNO) holds total assets worth $98.66 Million USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Alpha Teknova Inc - Total Assets Trend (2019–2025)
This chart illustrates how Alpha Teknova Inc's total assets have evolved over time, based on quarterly financial data. Also see TKNO market cap for the company's overall valuation and market capitalisation.
Alpha Teknova Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Alpha Teknova Inc's total assets of $98.66 Million consist of 33.3% current assets and 66.7% non-current assets. Review how much debt does Alpha Teknova Inc carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 5.7% |
| Accounts Receivable | $4.62 Million | 4.5% |
| Inventory | $7.05 Million | 6.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $11.94 Million | 11.5% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2019–2025)
This chart illustrates how Alpha Teknova Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Alpha Teknova Inc (TKNO) share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Alpha Teknova Inc's current assets represent 33.3% of total assets in 2025, an increase from 26.4% in 2019.
- Cash Position: Cash and equivalents constituted 5.7% of total assets in 2025, down from 7.1% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 63.0% in 2019.
- Asset Diversification: The largest asset category is intangible assets at 11.5% of total assets.
Alpha Teknova Inc Competitors by Total Assets
Key competitors of Alpha Teknova Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
|
China | CN¥4.49 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
Alpha Teknova Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.59 | 5.64 | 19.92 |
| Quick Ratio | 3.60 | 4.71 | 19.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $24.78 Million | $32.69 Million | $112.38 Million |
Alpha Teknova Inc - Advanced Valuation Insights
This section examines the relationship between Alpha Teknova Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.81 |
| Latest Market Cap to Assets Ratio | 1.98 |
| Asset Growth Rate (YoY) | -12.8% |
| Total Assets | $103.58 Million |
| Market Capitalization | $205.34 Million USD |
Valuation Analysis
Above Book Valuation: The market values Alpha Teknova Inc's assets above their book value (1.98x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: Alpha Teknova Inc's assets decreased by 12.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Alpha Teknova Inc (2019–2025)
The table below shows the annual total assets of Alpha Teknova Inc from 2019 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $103.58 Million | -12.79% |
| 2024-12-31 | $118.77 Million | -7.64% |
| 2023-12-31 | $128.59 Million | -15.55% |
| 2022-12-31 | $152.26 Million | -8.56% |
| 2021-12-31 | $166.51 Million | +164.68% |
| 2020-12-31 | $62.91 Million | +7.52% |
| 2019-12-31 | $58.51 Million | -- |
About Alpha Teknova Inc
Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company' primary products include pre-poured media plates for cell growth and cloning; liquid microbial culture media and supplements for cellular expansion; and molecular biology reagents for sam… Read more